These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24825094)

  • 1. Molecular functionality of CYP2C9 polymorphisms and their influence on drug therapy.
    Jarrar YB; Lee SJ
    Drug Metabol Drug Interact; 2014; 29(4):211-20. PubMed ID: 24825094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of 32 CYP2C9 allelic variants.
    Niinuma Y; Saito T; Takahashi M; Tsukada C; Ito M; Hirasawa N; Hiratsuka M
    Pharmacogenomics J; 2014 Apr; 14(2):107-14. PubMed ID: 23752738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CYP2C9 genetic polymorphisms in the oxidative metabolism of diclofenac in vitro.
    Xia MM; Wang L; PAan PP; Wang HY; Chen MC; Chen Y; Dai DP; Cai JP; Hu GX
    Pharmazie; 2014 Dec; 69(12):898-903. PubMed ID: 25951663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59.
    Dai DP; Wang SH; Li CB; Geng PW; Cai J; Wang H; Hu GX; Cai JP
    Drug Metab Dispos; 2015 Aug; 43(8):1246-9. PubMed ID: 25994031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-frequency variants at the
    Claudio-Campos K; Moneró-Paredes M; Hernández E; Renta J; Duconge J
    Pharmacogenomics; 2019 Aug; 20(12):891-902. PubMed ID: 31453773
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.
    Kousar S; Wafai ZA; Wani MA; Jan TR; Andrabi KI
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):504-16. PubMed ID: 25943175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro.
    Wang L; Bao SH; Pan PP; Xia MM; Chen MC; Liang BQ; Dai DP; Cai JP; Hu GX
    Drug Dev Ind Pharm; 2015; 41(8):1363-7. PubMed ID: 25144335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.
    Karnes JH; Rettie AE; Somogyi AA; Huddart R; Fohner AE; Formea CM; Ta Michael Lee M; Llerena A; Whirl-Carrillo M; Klein TE; Phillips EJ; Mintzer S; Gaedigk A; Caudle KE; Callaghan JT
    Clin Pharmacol Ther; 2021 Feb; 109(2):302-309. PubMed ID: 32779747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PharmVar GeneFocus: CYP2C9.
    Sangkuhl K; Claudio-Campos K; Cavallari LH; Agundez JAG; Whirl-Carrillo M; Duconge J; Del Tredici AL; Wadelius M; Rodrigues Botton M; Woodahl EL; Scott SA; Klein TE; Pratt VM; Daly AK; Gaedigk A
    Clin Pharmacol Ther; 2021 Sep; 110(3):662-676. PubMed ID: 34109627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrosequencing of the CYP2C9 -1766T>C polymorphism as a means of detecting the CYP2C9*8 allele.
    Patel SR; Langaee TY; Wong SS; Cavallari LH
    Pharmacogenomics; 2014 Sep; 15(13):1717-22. PubMed ID: 25410896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics: the influence of genomic variation on drug response.
    Thomas FJ; McLeod HL; Watters JW
    Curr Top Med Chem; 2004; 4(13):1399-409. PubMed ID: 15379653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People.
    McDonald MG; Henderson LM; Ray S; Yeung CK; Johnson AL; Kowalski JP; Hanenberg H; Wiek C; Thummel KE; Rettie AE
    J Pharmacol Exp Ther; 2020 Aug; 374(2):233-240. PubMed ID: 32423989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cytochrome P450 2C9 polymorphism on bosentan metabolism.
    Chen M; Zhang Y; Pan P; Wang L; Zhan Y; Jin H; Xia M; Wang X; Dai D; Cai J; Hu G
    Drug Metab Dispos; 2014 Nov; 42(11):1820-5. PubMed ID: 25142737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
    Franco V; Perucca E
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1269-79. PubMed ID: 26037375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism analysis of the drug-metabolizing enzyme CYP2C9 in a Chinese Tibetan population.
    Jin T; Geng T; He N; Shi X; Wang L; Yuan D; Kang L
    Gene; 2015 Aug; 567(2):196-200. PubMed ID: 25958051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of CYP2C9 polymorphism and phenytoin co-administration on acenocoumarol dose in patients with cerebral venous thrombosis.
    De T; Christopher R; Nagaraja D
    Thromb Res; 2014 May; 133(5):729-35. PubMed ID: 24530212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants.
    Hiratsuka M
    Biol Pharm Bull; 2016; 39(11):1748-1759. PubMed ID: 27803446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of human cytochrome P450 2C9 and the functional relevance.
    Zhou SF; Zhou ZW; Huang M
    Toxicology; 2010 Dec; 278(2):165-88. PubMed ID: 19715737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Functional Effects of
    Henderson LM; Hopkins SE; Boyer BB; Thornton TA; Rettie AE; Thummel KE
    Drug Metab Dispos; 2021 May; 49(5):345-352. PubMed ID: 33632714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations in drug-metabolizing enzyme CYP2C9 among major ethnic groups of Pakistani population.
    Hizbullah ; Ahmed S; Noor Mumtaz M; Zulfiqar Z; Amir Hamza S; Siraj S; Jelani M; Imran I; Khan A
    Gene; 2020 Jul; 746():144659. PubMed ID: 32276000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.